Early Prediction of Treatment Outcome in Head and Neck Cancer with 2-¹⁸FDG PET

References

• TNN Classification of Malignant Tumours. UICC. Springer Verlag. 1992, ISBN 0–387–17366–8
   Google Scholar
• Warburg O. On the origin of cancer cells. Science 1956; 123: 309–14
   PubMed Web of Science ®Google Scholar
• Mathupala S P, Rempel A, Pedersen P L. Glucose catabolism in cancer cells. Isolation, sequence and activity of the promoter for type II hexokinase. J Biol Chem 1995; 28: 16918–25
   Google Scholar
• Minn H, Lapela M, Klemi P, et al. Positron emission tomography in prediction of survival in head and neck cancer. Studies on clinical applications of positron emission tomography in oncology (dissertation), University of Turku, TurkuFinland 1996
   Google Scholar
• Nieweg O, Pruim J, van Ginkel J, et al. Fluorine-18-fluordeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med 1996; 37: 257–61
   PubMedGoogle Scholar
• Flier J S, Mueckler M M, Usher P, Lodish H F. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987; 235: 1492–5
   PubMed Web of Science ®Google Scholar
• Brown R S, Wahl R L. Overexpression of Glut-1 glucose transporter in human breast cancer. Cancer 1993; 72: 2979–85
   PubMed Web of Science ®Google Scholar
• Persons D A, Schek N, Hall B L, Finn O J. Increased expression of glycolysis-associated genes in oncogene-transformed and growth-accelerated states. Mol Carcinogenesis 1989; 2: 88–94
   PubMed Web of Science ®Google Scholar
• Andrich M P, Neumann R. The role of positron emission tomography imaging in early assessment of the antitumour impact of biologics and cytotoxics. Cur Opinion in Oncol 1994; 6: 627–32
   PubMedGoogle Scholar
• Wahl R L, Zasadny K, Helvie M, Hutchins G D, Weber B, Cody R. Metabolic monitoring of breast cancer, chemo-hormonotherapy, using positron emission tomography, an initial evaluation. J Clin Oncol 1993; 11: 2101–11
   PubMed Web of Science ®Google Scholar
• Sandell A, Ohlsson T, Erlandsson K, et al. A PET system based on 2-18FDG production with a low energy electrostatic proton accelerator and a dual headed PET scanner. Acta Oncol 1992; 31: 771–6
   PubMed Web of Science ®Google Scholar
• Erlandsson K, Strand S-E. A new approach to three-dimensional image reconstruction in PET. IEEE Trans Nucl Sci 1992; 39: 1438–43
   Google Scholar
• Ohlsson T, Sandell A, Hellborg R, et al. Clinical useful quantities of [18F] fluoride produced by 6 MeV proton irradiation of a H218O target. Nuclear Instruments and Methods in Physics Research 1996; 379: 341–2
   Google Scholar
• Toorongian S A, Mulholland G K, Jewtt D M, et al. Routine production of 2-deoxy-2[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary ammonium resin. Nucl Med Biol 1990; 17: 273–9
   Web of Science ®Google Scholar
• Rhodes C G, Wise R JS, Gibbs J M, et al. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol 1983; 14: 614–26
   PubMed Web of Science ®Google Scholar
• Sokoloff L, Reivich M, Kennedy C, et al. The [14C]-deoxyglucose method for the measurement of local cerebral glucose utilization. Theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28: 897–916
   PubMed Web of Science ®Google Scholar
• Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988; 29: 1521–5
   PubMed Web of Science ®Google Scholar
• Chaiken L, Rege S, Hoh C, et al. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27: 455–64
   PubMed Web of Science ®Google Scholar
• Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxy-glucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972–80
   PubMed Web of Science ®Google Scholar
• Strauss L G, Clorius J H, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989; 170: 329–32
   PubMed Web of Science ®Google Scholar
• Reisser C, Haberkorn U, Dimitrakopoulou A, Strauss A, Seifert E, Strauss L G. Chemotherapeutic management of head and neck malignancies with positron emission tomography. Arch Otolaryngol Head and Neck Surg 1995; 121: 272–6
   PubMedGoogle Scholar
• Seifert E, Schadel A, Haberkorn U, Strauss L G. Evaluating the effectiveness of chemotherapy in patients with head and neck tumours using positron emission tomography. HNO 1992; 40: 90–3
   PubMedGoogle Scholar
• Haberkorn U, Strauss L G, Dimitrakopoulou A, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993; 34: 12–17
   PubMed Web of Science ®Google Scholar
• Kapoor R R, Spence A M, Muzi M, Graham M M, Abott G L, Krohn K A. Determination of the deoxyglucose and glucose phosphorylation ratio and the lumped constant in rat brain and a transplantable rat glioma. J Neurochem 1989; 53: 37–44
   PubMed Web of Science ®Google Scholar
• Kato A, Diksic M, Yamamoto Y L, Feindel W. Quantification of glucose utilization in an experimental brain tumor model by the deoxyglucose method. J Cereb Blood Flow Metab 1985; 5: 108–14
   PubMedGoogle Scholar
• Langen K J, Braun U, Rota Kops E, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993; 34: 355–9
   PubMedGoogle Scholar